Coya Therapeutics to Present ALS Trial Biomarker Methodology at NEALS Meeting
Coya Therapeutics says it will present its neurofilament light chain biomarker stratification methodology for the ALSTARS trial at the 2026 Annual NEALS Meeting.
Coya Therapeutics says it will present its neurofilament light chain biomarker stratification methodology for the ALSTARS trial at the 2026 Annual NEALS Meeting.